Envista (NYSE:NVST) Releases FY 2025 Earnings Guidance

Envista (NYSE:NVST) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.950-1.050 for the period, compared to the consensus estimate of 1.120. The company issued revenue guidance of -.

Envista Price Performance

Shares of NVST traded up $0.45 during mid-day trading on Wednesday, reaching $20.58. The stock had a trading volume of 4,921,988 shares, compared to its average volume of 2,076,956. The firm has a market cap of $3.54 billion, a price-to-earnings ratio of -2.65, a PEG ratio of 1.82 and a beta of 1.34. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. The business has a fifty day moving average of $20.00 and a 200 day moving average of $19.09. Envista has a 12 month low of $15.15 and a 12 month high of $24.79.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Equities analysts predict that Envista will post 0.72 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on NVST shares. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Wells Fargo & Company started coverage on Envista in a research report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price objective for the company. Jefferies Financial Group lifted their price objective on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Mizuho assumed coverage on Envista in a research note on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price objective for the company. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $20.21.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.